Midday 20th March 2020 -Trial Suspension
We are sorry to announce a suspension of the PITHIA trial until further notice. The decision has not been taken lightly, but given the current situation with COVID-19 in the UK and disruption to donation and transplant services, we could not continue to run the trial as normal. We hope this will free laboratory and clinical staff to focus on the emergency response and try to minimise disruption to the trial design. We will try to restart the trial (from the same point) as soon as possible, although this is likely to be some months away. Thank you all for your support for the trial so far, we will update you as soon as we have more information. Good luck!
1st November 2019: Randomisation Announcement for phase 5 – Laura Pankhurst, Trial Statistician.
PITHIA Newsletter  November 2017 – HRA and Ethics submission
PITHIA_Newsletter _January 2018 – First centres get R&D approvals
PITHIA_Newsletter _February 2018 – More centres come online
PITHIA_Newsletter _June 2018 – Scanners installed in Cambridge, Royal Free, Newcastle and Birmingham
PITHIA_Newsletter _September 2018 – We’re ready to go. Start date 1st October 2018
PITHIA Trial Meeting Agenda - 1st March 2019 Trial Update - Dominic Summers Biopsy Method - Tobi Ayorinde Review of Month 1 - Emma Laing Dual Transplantation - Maria Ibrahim Experience from Portsmouth - Paul Gibbs Kidney Allocation - Lisa Mumford NHSBT Hub Operations Team - Mick Stokes What does PITHIA mean for your centre - Gavin Pettigrew The Announcement - Helen Thomas
Introduction Emma Laing National Requirement for Histopathology Roberto Cacciola PITHIA Overview Gavin Pettigrew & Dom Summers Interpreting the Remuzzi Score Desley Neil Cambridge Histopathology Meryl Griffiths Principles of the SW-CRT Karla Hemming Data Collection and Analysis Laura Pankhurst Digital Pathology Simon Kimber Economic Analysis Ed Wilson Expansion of DCD Kidney Transplantation Gavin Pettigrew Logistical Aspects of the Trial Claire Williment